The markets closed mixed with the Dow dropping 37 points to 18,576 as crude oil prices rose while producer prices dropped. Nasdaq rose 4 points to 5,232.
On the upside
Eleven Biotherapeutics (Nasdaq: EBIO) narrowed losses for the second quarter as revenue rose.
Pacific Crest upgraded InvenSense (NYSE: INVN) from a Sector Weight rating to an Overweight rating citing significant growth opportunities for the smartphone gyroscope maker.
Anavex Life Sciences (Nasdaq: AVXL) narrowed losses for the second quarter.
On the downside
Ruby Tuesday (NYSE: RT) fell to a greater than expected loss for the fourth quarter and announced plans to close 95 underperforming restaurants.
Investors locked in profits on Uranium Resources (Nasdaq: URRE).
Profit taking weighed down shares of Kraton Performance Polymers (NYSE: KRA).
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 slipped a point to 2,184. Bitcoin lost $4 to $585.
